Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

40.20
-1.1100-2.69%
Volume:114.59K
Turnover:4.57M
Market Cap:1.39B
PE:-10.15
High:41.06
Open:41.06
Low:39.20
Close:41.31
Loading ...

Insider Shake-Up: Disc Medicine Directors Make Major Stock Moves!

TIPRANKS
·
27 Mar

With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing

Simply Wall St.
·
23 Mar

Victoria's Secret, Bitdeer, and More Stocks See Activist Action -- Barrons.com

Dow Jones
·
22 Mar

Disc Medicine Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
18 Mar

Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald

TIPRANKS
·
18 Mar

Disc Medicine (IRON) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
18 Mar

All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy

Zacks
·
15 Mar

Disc Medicine Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Disc Medicine (IRON) and PTC Therapeutics (PTCT)

TIPRANKS
·
07 Mar

Disc Medicine Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
03 Mar

Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know

Zacks
·
03 Mar

Disc Medicine price target raised to $75 from $73 at Scotiabank

TIPRANKS
·
03 Mar

Promising Prospects for Disc Medicine: Buy Rating Backed by Bitopertin’s Potential and Strong Financial Health

TIPRANKS
·
28 Feb

Disc Medicine’s 2024 Financial Results and Clinical Progress

TIPRANKS
·
28 Feb

Disc Medicine's Annual Loss Widens in 2024

MT Newswires Live
·
27 Feb

Earnings Flash (IRON) Disc Medicine Posts Full Year 2024 Net Loss $-3.96 a Share, vs. FactSet Est of $-4.23 Loss

MT Newswires Live
·
27 Feb

Disc Medicine FY 2024 GAAP EPS $(3.96) Beats $(4.38) Estimate

Benzinga
·
27 Feb

TD Cowen Initiates Coverage on Disc Medicine With Buy Rating

MT Newswires Live
·
27 Feb

Disc Medicine FY Basic EPS USD -3.96 VS. Ibes Estimate USD -4.14

THOMSON REUTERS
·
27 Feb

Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
27 Feb